Shanghai Pharmaceuticals: Controlling shareholder Shanghai Pharma plans to increase its holding from 55 million shares to 74 million shares of the company's H shares.

Shanghai Pharmaceuticals announced that its controlling shareholder, Shanghai Industry Company Limited, plans to increase its H-shareholding within the next 12 months through its wholly-owned subsidiary, Shangshi International Investment Limited, via the Stock Exchange of Hong Kong Limited, through centralized bidding. The total number of shares to be increased is 55 to 74 million shares, not exceeding 2% of the total voting shares of the company.